-
Young Colorectal Cancer Patients Are Often Misdiagnosed
A new survey suggests that young adults with colorectal cancer struggle to receive an accurate, prompt diagnosis.
by Bradley Jones
-
February 22: The Week in Cancer News
Trials indicate that a combination of a targeted therapy and immunotherapy can treat advanced kidney cancer, and a study identifies a genetic variant associated with smoking menthol cigarettes.
by Kate Yandell
-
February 15: The Week in Cancer News
Guidelines recommend that all breast cancer patients be offered genetic testing, and a report indicates that disparities in cancer incidence and mortality between black and white Americans are getting smaller.
by Kate Yandell
-
Considering the Term “Cancer Survivor”
A study investigates how people who have been diagnosed with cancer feel about being called survivors.
by Jen Tota McGivney
-
February 8: The Week in Cancer News
A study finds that a new shingles vaccine is safe and likely effective in adult cancer patients, and a review article shows that some cancer patients with HIV can benefit from immunotherapy.
by Kate Yandell
-
Making Clinical Trials More Inclusive
Broadening clinical trial eligibility criteria to include cancer patients who also have other health conditions could increase trial enrollment.
by Ashley P. Taylor
-
February 1: The Week in Cancer News
Unsupported claims of a “complete cure” for cancer spread across the internet and airwaves, and a new policy aims to increase inclusion of older patients in research.
by Kate Yandell
-
January 25: The Week in Cancer News
A trial finds that it is safe to take a hormone-blocking drug to reduce prostate cancer risk, and direct-to-consumer genetic testing for cancer risk factors expands.
by Kate Yandell
-
What Do Clinical Trial Endpoints Really Measure?
A study investigates whether a commonly used clinical trial endpoint, progression-free survival, can be used to predict quality of life.
by Jon Kelvey
-
January 18: The Week in Cancer News
A study sheds light on predicting immunotherapy response, and a company starts testing a digital chemotherapy pill.
by Kate Yandell
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona